phenyl acetate has been researched along with Escherichia coli Meningitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, KS; Liu, W; Prakash, A; Zhang, C; Zhu, N | 1 |
| Kim, KS; Pearce, D; Zhu, L | 1 |
2 other study(ies) available for phenyl acetate and Escherichia coli Meningitis
| Article | Year |
|---|---|
Targeting E. coli invasion of the blood-brain barrier for investigating the pathogenesis and therapeutic development of E. coli meningitis.
Topics: Acetates; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Ceftriaxone; Cells, Cultured; Cyclopropanes; Cysteine; Drug Therapy, Combination; Endothelial Cells; ErbB Receptors; Escherichia coli; Female; Gefitinib; Humans; Infant, Newborn; Leukotriene Antagonists; Leukotrienes; Male; Meningitis, Escherichia coli; Mice; Permeability; Phospholipases A2, Cytosolic; Quinolines; Sphingosine-1-Phosphate Receptors; Sulfides | 2020 |
Prevention of Escherichia coli K1 penetration of the blood-brain barrier by counteracting the host cell receptor and signaling molecule involved in E. coli invasion of human brain microvascular endothelial cells.
Topics: Acetates; Animals; Animals, Newborn; Blood-Brain Barrier; Brain; Cells, Cultured; Cyclopropanes; Endothelial Cells; Escherichia coli; Etoposide; Female; Humans; Leukotriene Antagonists; Meningitis, Escherichia coli; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Laminin; Sulfides | 2010 |